Clover Health Investments, Corp. (CLOV)
NASDAQ: CLOV · Real-Time Price · USD
2.630
-0.060 (-2.23%)
At close: Aug 28, 2025, 4:00 PM
2.640
+0.010 (0.38%)
After-hours: Aug 28, 2025, 7:56 PM EDT

Clover Health Investments Stock Forecast

Stock Price Forecast

The 3 analysts that cover Clover Health Investments stock have a consensus rating of "Strong Buy" and an average price target of $4.37, which forecasts a 66.16% increase in the stock price over the next year. The lowest target is $3.00 and the highest is $6.00.

Price Target: $4.37 (+66.16%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$3.00$4.37$4.10$6.00
Change+14.07%+66.16%+55.89%+128.14%

Analyst Ratings

The average analyst rating for Clover Health Investments stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy222222
Buy000000
Hold111111
Sell000000
Strong Sell000000
Total333333

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Canaccord Genuity
Canaccord Genuity
Strong Buy
Maintains
$4.5$4.1
Strong BuyMaintains$4.5$4.1+55.89%Aug 7, 2025
UBS
UBS
Hold
Maintains
$4.5$3
HoldMaintains$4.5$3+14.07%Aug 6, 2025
Canaccord Genuity
Canaccord Genuity
Strong Buy
Maintains
$4.2$4.5
Strong BuyMaintains$4.2$4.5+71.10%Mar 3, 2025
Craig-Hallum
Craig-Hallum
Strong Buy
Initiates
$6
Strong BuyInitiates$6+128.14%Dec 17, 2024
UBS
UBS
Hold
Initiates
$4
HoldInitiates$4+52.09%Oct 7, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
1.92B
from 1.37B
Increased by 39.93%
Revenue Next Year
2.44B
from 1.92B
Increased by 27.06%
EPS This Year
-0.12
from -0.09
EPS Next Year
-0.10
from -0.12
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
690.02M1.36B1.20B1.26B1.37B1.92B2.44B
Revenue Growth
51.74%97.30%-11.91%5.32%8.52%39.93%27.06%
EPS
-1.54-1.42-0.71-0.44-0.09-0.12-0.10
EPS Growth
-------
Forward PE
-------
No. Analysts
-----66
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High2.0B2.7B
Avg1.9B2.4B
Low1.8B2.2B

Revenue Growth

Revenue Growth20252026202720282029
High
45.7%
42.2%
Avg
39.9%
27.1%
Low
32.7%
14.9%

EPS Forecast

EPS20252026202720282029
High-0.11-0.03
Avg-0.12-0.10
Low-0.15-0.15

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.